학술논문

Phase II study of tivantinib (ARQ 197) and cetuximab in patients with EGFR inhibitor-resistant, MET-High, KRAS wild-type (KRASwt) metastatic colorectal cancer (mCRC)

Document Type

Article

Author

Rimassa, L.; Bozzarelli, S.; Tronconi Maria, C.; Giordano, L.; Santoro, A.; Cordio, S.; Pietrantonio, F.; Toppo, L.; Liguigli, W.; Lonardi, S.; Zagonel, V.; Zaniboni, A.; Bordonaro, R.; Di Bartolomeo, M.; Di Tommaso, L.

Source

In: Annals of oncology : official journal of the European Society for Medical Oncology. (Annals of oncology : official journal of the European Society for Medical Oncology, 1 June 2017, 28:iii11)

Subject

Language

English

ISSN

15698041

Online Access

Full Text (ScienceDirect 종량제) Full Text (ScienceDirect O/A) Open Access (EBSCO) Web of Science JCR 저널정보 Scopus Find it@PNU

이메일

부산대학교 도서관

Online Access

메일 발송